Services / Cancer Care / Research / Clinical Trials /

Clinical Trial

« Back to List

GI 164

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: December 31, 2012

Status:
Research Hotline:

Details: A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined with Gemcitabine as First Line Treatment for Metastatic Pancreatic Adenocarcinoma. 

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share